⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9785063 | 0.96 | — | — | |
| SCHEMBL1471025 | 0.72 | — | — | |
| SCHEMBL1470978 | 0.70 | — | — | |
| SCHEMBL7483138 | 0.70 | — | — | |
| SCHEMBL22808917 | 0.70 | — | — | |
| SCHEMBL21984637 | 0.64 | — | — | |
| SCHEMBL1452449 | 0.64 | — | — | |
| SCHEMBL12053187 | 0.64 | — | — | |
| SCHEMBL1473070 | 0.62 | — | — | |
| SCHEMBL14548427 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| US-20230364183-A1 | CARTILAGE-HOMING PEPTIDES | FRED HUTCHINSON CANCER CENTER | 2023-11-16 | — | — | US | disclosed |
| US-20230226186-A1 | RAS INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT | 2023-07-20 | — | — | US | disclosed |
| US-11690915-B2 | Ras inhibitors | Revolution Medicines, Inc. (US) | 2023-07-04 | — | — | US | disclosed |
| WO-2023001841-A1 | COMPOSITION COMPRISING A SPECIFIC COMBINATION OF SURFACTANTS AND A CATIONIC POLYMER | L'OREAL (FR) | 2023-01-26 | — | — | WO | disclosed |
| EP-3453707-B1 | BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHANGHAI DE NOVO PHARMATECH CO LTD (CN) | 2022-02-16 | — | — | EP | disclosed |
| WO-2021237309-A1 | MULTI-STIMULI RESPONSIVE METAL-ORGANIC FRAMEWORKS | THE UNIVERSITY OF SYDNEY (AU) | 2021-12-02 | — | — | WO | disclosed |
| US-20210340266-A1 | ANTIBODY MOLECULES TO APRIL AND USES THEREOF | VISTERRA INC (US) | 2021-11-04 | — | — | US | disclosed |
| US-20210251270-A1 | HUMAN AND NON-HUMAN ANIMAL USE OF MICROBIAL ANAPLEROTIC OIL | HELIAE DEVELOPMENT, LLC | 2021-08-19 | — | — | US | disclosed |
| EP-2809517-B1 | NON WOVEN FABRIC SUITABLE FOR WET OR HUMID AREAS | MUNKSJOE AHLSTROM OYJ (FI) | 2021-05-12 | — | — | EP | disclosed |
| WO-2010130773-A2 | BENZOXAZOLONE DERIVATIVES AS ALDOSTERONE SYMTHASE INHIBITORS | NOVARTIS AG (CH) | 2010-11-18 | — | — | WO | disclosed |
| US-20100160599-A1 | OLIGOPHOSPHAZENE COMPOUND | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100029625-A1 | Therapeutic Agent for Restenosis | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090311473-A1 | HEAT-ACTIVATEDLY BONDABLE 2D DIECUTTING ELEMENT | TESA AG (DE) | 2009-12-17 | — | — | US | disclosed |
| US-20080262049-A1 | Therapeutic Agent for Hematopoietic Tumor | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| US-20080234289-A1 | Melanocortin Receptor-Specific Compounds | PALATIN TECHNOLOGIES, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080194653-A1 | Therapeutic Agent For Solid Tumor | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-08-14 | — | — | US | disclosed |
| EP-1908755-A1 | THERAPEUTIC AGENT FOR RESTENOSIS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-04-09 | — | — | EP | disclosed |
| EP-1870404-A1 | AGENT FOR TREATMENT OF HEMATOPOIETIC TUMOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-12-26 | — | — | EP | disclosed |
| EP-1867640-A1 | AGENT FOR TREATMENT OF SOLID TUMOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-12-19 | — | — | EP | disclosed |